Development of RET Kinase Inhibitors for Targeted Cancer Therapy

Volume: 18, Issue: 2, Pages: 162 - 175
Published: Jan 1, 2011
Abstract
RET (Rearranged during Transfection) is a transmembrane tyrosine kinase expressed in central and peripheral nervous system and neural crest-derived cells and acts as a co-receptor of GDNF family neurotrophic factor in complex with GRFα family proteins. RET protein comprises an extracellular portion with four cadherine-like domains and a cysteine- rich region important for intermolecular interactions; a hydrophobic transmembrane domain; an...
Paper Details
Title
Development of RET Kinase Inhibitors for Targeted Cancer Therapy
Published Date
Jan 1, 2011
Volume
18
Issue
2
Pages
162 - 175
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.